Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FQ78Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $157,791
Award facts
- Contract value 100% obligated
- $157,791.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $157,791.49 for Cosentyx (secukinumab) 300mg dose auto-injector pens. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 19, 2025, issued on September 18, 2025. The contract calls for performance and delivery in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and running through December 2026. The SPE2DX contract serves as a global pharmaceutical support mechanism enabling AmerisourceBergen to supply military healthcare systems worldwide with brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
This award reflects AmerisourceBergen's established role as a critical vendor within the Defense Health Supply Chain, supporting military and veteran healthcare systems through open competition. Cosentyx, a biologic immunosuppressant used primarily for autoimmune conditions, represents the type of specialty pharmaceutical product routinely procured through the DLA Troop Support Medical contract. As the prime contractor on this delivery order and the broader SPE2DX vehicle, AmerisourceBergen continues to serve as a key supplier to the Defense Health Agency and other federal healthcare customers, with no set-aside designation applied to this award.
Quick answers
Who was awarded contract SPE2DB25FQ78Y?
SPE2DB25FQ78Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FQ78Y worth?
The government has obligated $157,791 on SPE2DB25FQ78Y.
Is contract SPE2DB25FQ78Y an order under another contract?
Yes. SPE2DB25FQ78Y is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ78Y competed?
The extent of competition for SPE2DB25FQ78Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award